These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4761563)

  • 1. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
    MARQUES M; RIETCORREA P
    Folia Endocrinol; 1964 Jun; 17():381-6. PubMed ID: 14210726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypoglycemic sulfonamides].
    Loubatières AL
    Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of chlorpropamide and tolbutamide on adenylate cyclase activity in rat heart and liver.
    Leichter SB; Galasky SP
    Biochem Pharmacol; 1981 Oct; 30(20):2861-3. PubMed ID: 7317079
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypoglycemic drugs.
    Stehling L
    Clin Anesth; 1974; 10(1):233-47. PubMed ID: 4598996
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity.
    Warnick PR; Davis FB; Davis PJ; Mylotte KM; Blas SD
    Diabetes; 1986 Sep; 35(9):1044-8. PubMed ID: 2943619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of sulphonylureas to serum albumin.
    Crooks MJ; Brown KF
    J Pharm Pharmacol; 1974 May; 26(5):304-11. PubMed ID: 4153105
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism in vitro of 5,5-diphenylhydantoin.
    Gabler WL; Hubbard GL
    Biochem Pharmacol; 1972 Nov; 21(22):3071-3. PubMed ID: 4405453
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood glucose and drug levels in normal fasting subjects following single oral doses of tolazamide and chlorpropamide.
    Novak E; Borden K; Vitti T; Hearron M
    Mich Med; 1969 Dec; 68(24):1243-5. PubMed ID: 4901022
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tolbutamide and of chlorpropamide on fatty acid synthesis.
    Gonçalves J; Favarger P; Rous S
    Biochem Pharmacol; 1972 Oct; 21(20):2793-800. PubMed ID: 4647084
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic effects of hypoglycemic sulfonylureas. I. In vitro effect of sulfonylureas on leucine incorporation and metabolism and on respiration of rat tissues.
    De Schepper PJ
    Biochem Pharmacol; 1967 Dec; 16(12):2337-53. PubMed ID: 6075395
    [No Abstract]   [Full Text] [Related]  

  • 12. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
    SMITH DL; VECCHIO TJ; FORIST AA
    Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial with tolazamide, a new hypoglycemia agent; its potency compared to chlorpropamide.
    Quismorio FT; Villadolid LS; Egay LM; Wico AR; Llamas SP; Acurantes AI
    Acta Med Philipp; 1967; 3(4):261-5. PubMed ID: 6069635
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R; DALLECOSTE P
    Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic effect of sulfonylureas.
    Marshall A; Gingerich RL; Wright PH
    Metabolism; 1970 Dec; 19(12):1046-52. PubMed ID: 5492043
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of tolbutamide and chlorpropamide on acetaldehyde metabolism in two inbred strains of mice.
    Little RG; Petersen DR
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):206-14. PubMed ID: 4024111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of phenytoin in body fluids in the presence of sulphonyl urea compounds.
    Thürkow I; Wesseling H; Meijer DK
    Clin Chim Acta; 1972 Mar; 37():509-13. PubMed ID: 5022115
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of diuresis in the rat by chlorpropamide, glibenclamide and tolbutamide.
    Foy JM; Lucas PD
    Experientia; 1975 May; 31(5):570-3. PubMed ID: 237771
    [No Abstract]   [Full Text] [Related]  

  • 19. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of insulin, chlorpropamide and tolbutamide on the metabolism of branched chain amino acids.
    Penttilä IM
    Ann Med Exp Biol Fenn; 1966; 44():Suppl 11:1-42. PubMed ID: 5945371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.